Chlorpromazine Toxic Dose
In adults, chlorpromazine toxicity typically occurs at doses exceeding 1000 mg, with blood concentrations above 1000 ng/mL associated with severe toxicity and death; in children, ingestion of as little as 15 mg/kg (approximately one tablet in young children) can cause significant symptoms requiring hospitalization.
Adult Toxic Dose
The toxic threshold in adults is poorly defined in guidelines, but case reports provide critical data:
- Fatal blood concentration: A documented case of sudden death occurred with a blood chlorpromazine concentration of 1534 ng/mL after receiving a mean daily dose of 780 mg for 5 days in a patient with renal insufficiency 1
- Therapeutic vs. toxic range: Blood levels of 0.64 μg/mL (640 ng/mL) were found in the toxic range in a fatal overdose case 2
- Dose-mortality relationship: In young adults (18-24 years), doses >100 mg chlorpromazine equivalents were associated with significantly increased mortality (127.5 additional deaths per 100,000 person-years) 3
Clinical Context for Adults
The FDA label emphasizes that chlorpromazine has a narrow therapeutic window, particularly in vulnerable populations 4. Toxicity risk increases with:
- Renal insufficiency (reduced clearance)
- Hepatic disease (impaired metabolism)
- Concomitant CNS depressants
- Chronic high-dose therapy
Common pitfall: The antiemetic effect may mask signs of toxicity from other drugs, delaying recognition of overdose 4.
Pediatric Toxic Dose
The toxic dose in children is substantially lower and better defined:
- Estimated toxic dose: 15 mg/kg for chlorpromazine 5
- Single tablet risk: Most antipsychotics, including chlorpromazine, can cause severe effects with ingestion of just one tablet in young children 5
- Duration of toxicity: Symptoms typically last 1-3 days, with extrapyramidal symptoms often delayed 12-24 hours 5
Pediatric Clinical Features
In children, chlorpromazine poisoning characteristically causes 5:
- CNS depression (primary feature)
- Hypotension
- Miosis
- Extrapyramidal symptoms (less common than with haloperidol)
- Cardiac effects (rare)
Critical consideration: Children aged 5-17 years did not show increased mortality with antipsychotic use in a large cohort study, but doses should still be minimized 3.
Dose-Response Relationships
Evidence from controlled trials provides therapeutic context 6:
- Low dose: ≤400 mg/day
- Medium dose: 401-800 mg/day
- High dose: >800 mg/day
Key finding: High doses (>800 mg/day) showed increased efficacy but significantly more extrapyramidal symptoms (RR 0.43,95% CI 0.32-0.59) and higher dropout rates due to adverse effects 6.
Management Implications
For Suspected Overdose:
Adults: Consider toxicity with:
- Single doses >1000 mg
- Blood levels >1000 ng/mL
- Any dose in patients with renal/hepatic impairment
Children: Hospitalize if:
- Ingestion ≥15 mg/kg
- Any symptomatic child
- Ingestion of one or more tablets in young children (<6 years)
Monitoring duration: Observe for at least 24 hours due to delayed extrapyramidal symptoms 5
Treatment Approach:
- Supportive care is primary (no specific antidote)
- Anticholinergics (e.g., diphenhydramine) for extrapyramidal symptoms 7
- Avoid flumazenil if benzodiazepine co-ingestion suspected (may precipitate seizures) 8, 9
- Monitor for propylene glycol toxicity if using lorazepam for agitation 10
Special populations warning: The FDA label specifically warns about increased sensitivity in patients with hepatic encephalopathy, where even therapeutic doses may cause severe CNS effects 4.